What are you looking for?
Need help finding what you are looking for? Contact Us

PUBLISHER: Mordor Intelligence Pvt Ltd | PRODUCT CODE: 946278

Cover Image

PUBLISHER: Mordor Intelligence Pvt Ltd | PRODUCT CODE: 946278

Traumatic Brain Injury Assessment and Management Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

PAGES: 110 Pages
DELIVERY TIME: 2-3 business days
PDF & Excel (Single User License)
USD 4750
PDF & Excel (Team License: Up to 7 Users)
USD 5250
PDF & Excel (Site License)
USD 6500
PDF & Excel (Corporate License)
USD 8750

Add to Cart

The Traumatic Brain Injury Assessment and Management Devices market studied is anticipated to grow with a CAGR of nearly 5.4%, during the forecast period.

Certain factors that are driving the market growth include increasing incidence of traumatic brain injuries and technological advancements.

The increasing incidence of traumatic brain injuries (TBI) have been creating a significant pressure on the healthcare systems across the globe. Therapy for TBI usually begins in the hospital and continues at an inpatient rehabilitation unit, a residential treatment facility or through outpatient services.

The type and duration of rehabilitation is different for everyone, depending on the severity of the brain injury and what part of the brain was injured. People with mild traumatic brain injuries may also have other injuries that need to be addressed.

Additional treatments in the emergency room or intensive care unit of a hospital generally focus on minimizing secondary damage due to inflammation, bleeding or reduced oxygen supply to the brain.

Key Market Trends

Pressure Monitors show Lucrative Growth Opportunity in the Global Traumatic Brain Injury Assessment and Management Devices Market

Increased intracranial pressure is a rise in the pressure inside the skull that can result from or cause brain injury. Intracranial Pressure monitoring systems and devices help in monitoring the pressure, as increase in intracranial pressure can be serious and life-threatening medical problem. The pressure can damage the brain or spinal cord by pressing on important structures and by restricting blood flow into the brain. Increasing cases of head injury and increasing prevalence of neurodegenerative disorders have been key factors that have helped this segment grow. Moreover, increasing awareness regarding head injuries and technological advancements have also propelled the growth of this segment.

North America Dominates the Global Traumatic Brain Injury Assessment and Management Devices Market

Traumatic brain injury (TBI), also known as acquired brain injury, head injury, or brain injury, causes substantial disability and mortality in the American population. It occurs when a sudden trauma damages the brain and disrupts normal brain function. TBI often has profound physical, psychological, cognitive, emotional, and social effects on the lives of American people. TBI appears to be vastly under-diagnosed in the setting of systemic trauma, even in trauma centers. According to the CDC, there were approximately 2.8 million TBI-related emergency department visits, hospitalizations, and deaths in the United States in 2015. Hence, the rising prevalence of TBI is expected to drive the overall growth of the market across the entire region.

Competitive Landscape

The global Traumatic Brain Injury Assessment and Management Devices market is competitive and consists of a few major players. Companies like BioDirection, BrainScope, Compumedics, Elekta AB, Integra Lifesciences, Natus Medical Incorporated, Neural Analytics, Inc., Nihon Kohden Corporation, among others, hold the substantial market share in the market.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support
Product Code: 69921



  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study




  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Incidence of Traumatic Brain Injuries
    • 4.2.2 Technological Advancements
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Advanced Devices
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry


  • 5.1 By Device Type
    • 5.1.1 Imaging Devices
    • 5.1.2 Pressure Monitors
    • 5.1.3 Point-of-Care Testing Devices
    • 5.1.4 Others
  • 5.2 By End-User
    • 5.2.1 Hospitals
    • 5.2.2 Diagnostic Centers
    • 5.2.3 Others
  • 5.3 Geography
    • 5.3.1 North America
      • United States
      • Canada
      • Mexico
    • 5.3.2 Europe
      • Germany
      • United Kingdom
      • France
      • Italy
      • Spain
      • Rest of Europe
    • 5.3.3 Asia-Pacific
      • China
      • Japan
      • India
      • Australia
      • South Korea
      • Rest of Asia-Pacific
    • 5.3.4 Middle-East and Africa
      • GCC
      • South Africa
      • Rest of Middle-East and Africa
    • 5.3.5 South America
      • Brazil
      • Argentina
      • Rest of South America


  • 6.1 Company Profiles
    • 6.1.1 BioDirection
    • 6.1.2 BrainScope
    • 6.1.3 Compumedics
    • 6.1.4 Elekta AB
    • 6.1.5 Integra Lifesciences
    • 6.1.6 Natus Medical Incorporated
    • 6.1.7 Neural Analytics, Inc.
    • 6.1.8 Nihon Kohden Corporation


Have a question?

Jeroen Van Heghe

Manager - EMEA



Christine Sirois

Manager - Americas


Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!